BG
NVAX icon

Bellevue Group’s Novavax NVAX Stock Holding History

Bellevue Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,400
Closed -$1.49M – 195
2021
Q4 		$1.49M Sell
10,400
-5,600
-35% -$962K 0.02% 152
2021
Q3 		$3.32M Buy
+16,000
New +$3.53M 0.03% 139
2017
Q2 		– Sell
-16,250
Closed -$416K – 136
2017
Q1 		$416K Hold
16,250
– – 0.06% 127
2016
Q4 		$410K Hold
16,250
– – 0.08% 113
2016
Q3 		$676K Hold
16,250
– – 0.12% 109
2016
Q2 		$2.36M Hold
16,250
– – 0.44% 67
2016
Q1 		$1.68M Buy
+16,250
New +$1.74M 0.3% 83

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bellevue Group's NVAX Position: Q1 2022 in Review

Bellevue Group sold out of Novavax (NVAX) in Q1 2022, closing a stake of 10,400 shares — an estimated $1.49M sold.

Bellevue Group first reported a position in NVAX in Q1 2016 and held it in 7 quarters. The position peaked at $3.32M in Q3 2021. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Bellevue Group reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Bellevue Group sold 10,400 Novavax shares in Q1 2022, an estimated $1.49M.
  • Bellevue Group first reported a position in Novavax in Q1 2016 and held it in 7 quarters.
  • Bellevue Group's Novavax position peaked at $3.32M in Q3 2021.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Bellevue Group's 13F filing for Q1 2022, filed 13 May 2022.